VCs target pain treatments, but without the opioids

Opioid VC Venture
Medical illustration. Pills of all kinds, shapes and colours, March 2003. REUTERS/Jacky Naegelen JNA/
Ken Hood, managing director at FusionX Ventures, knows how easily good people can fall into the addiction trap. Not long ago, he spent a week in hospital due to complications from knee surgery. “I can’t tell you how many times ...

This content is available for Venture Capital subscribers only. Request a free trial to get access for a limited period

Venture Capital

Subscribe Now Request Trial

If you already have an active Venture Capital subscription, please sign in to view this article.